OWLO

📍 Paris, France🗓 Founded 2024👥 7 employees💰 Last funded Jul 2025
Medical Equipment Manufacturing
LinkedIn
Founded as a spin-off from CNRS lab Institut Langevin, OWLO is building next generation microscopy for healthcare. Our unique technology is the first to provide real-time 3D imaging in a non invasive way. Powered by AI image analysis, this innovation will change research and medical practice by making visible and quantifying what was previously unseen. Our first use case is in Assisted Reproductive Technologies (ART) where 75% of embryos transfers fail today, resulting in long and expensive procedures that are very stressful and demanding for women. We provide an entirely new way of looking at embryos with new indicators to predict their viability before implantation to improve the efficiency of the procedure and reduce its cost.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2024
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in OWLO?
OWLO has 1 investors on record on gritt.io, including 1 early-stage backers.
When did OWLO last raise funding?
The most recent investment in OWLO recorded on gritt.io was in July 2025.
When was OWLO founded?
OWLO was founded in 2024.
What industry is OWLO in?
OWLO operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is OWLO based?
OWLO is headquartered in Paris, France.